Craft
AstraZeneca revenue increased from $22.1 billion in 2018 to $24.4 billion in 2019, a (10.4%) increase.

Annual Revenue ($)

AstraZeneca revenue was $24.38 b in FY, 2019 which is a (10.4%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019
Revenue$22.47 b$22.09 b$24.38 b
Growth(2.00%)(1.67%)10.38%
Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020
Revenue$5.41 b$5.05 b$6.23 b$5.18 b$5.16 b$5.34 b$5.49 b$5.82 b$6.41 b$6.35 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

AstraZeneca revenue breakdown by business segment: 10.7% from Other Disease Areas, 22.1% from Respiratory, Inflammation and Autoimmunity, 35.5% from Oncology, 28.3% from Cardiovascular and Metabolic Diseases and 3.4% from Other

AstraZeneca revenue breakdown by geographic segment: 17.1% from Continental Europe, 38.3% from Americas, 37.2% from Asia, Africa & Australasia and 7.5% from UK

FY, 2019FY, 2018FY, 2017
Collaboration Revenue$819 m$1.04 b$2.31 b
Other Disease Areas$2.6 b$3.4 b$4.16 b
Respiratory, Inflammation and Autoimmunity$5.39 b$4.91 b$4.71 b
Oncology$8.67 b$6.03 b$4.02 b
Cardiovascular and Metabolic Diseases$6.91 b$6.71 b$7.27 b
FY, 2019FY, 2018FY, 2017
Continental Europe$4.16 b$380 m$4.56 b
Americas$9.33 b$8.53 b$7.96 b
Asia, Africa & Australasia$9.07 b$7.35 b$6.71 b
UK$1.82 b$2.39 b$3.24 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu